Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
55 participants
OBSERVATIONAL
2018-12-01
2021-07-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy controls - cross-sectional project design
No interventions assigned to this group
Patients - cross-sectional project design
No interventions assigned to this group
Patients - longitudinal project design
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent
* General consent
* Spinal cord injury (SCI)
* ASIA A-D injury with lowest extent of lesion between C1 and Th12
* Mini-Mental stat examintation score \> 26
* Age 18-80
* Written informed consent
* General consent
Exclusion Criteria
* Clinically significant conditions such as severe cardiovascular, pulmonary or malignant disease
* Pure cauda equina i.e. peripheral nerve injury
* Reliance on walking aids / prostheses for mobilisation
* Orthopaedic diagnosis with potential impact on gait
* Previous operations on the lower limbs or spine with potential impact on gait
* Inabilitay to undertake any component of the trial protocol
* Clinically significant conditions such as severe cardiovascular, pulmonary or malignant disease
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Balgrist
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-01451
Identifier Type: -
Identifier Source: org_study_id